The CME Group originally planned to launch these contracts as early as early as October, but it will not be able to obtain regulatory approval at that time. According to a letter to the exchange, the US Commodity Futures Trading Commission, which oversees the futures market, is extending the review period to thoroughly study the operating mechanism of such contracts and seek opinions from the wider industry. The CFTC confirmed in a letter sent on September 21 that the product will not go live as scheduled next month. The CFTC stated that since the product involved “novel or complex” issues, regulators needed more time to evaluate CME's application and decided to extend the review period by 45 days until November 9.

The CME Group originally planned to launch these contracts as early as early as October, but it will not be able to obtain regulatory approval at that time. According to a letter to the exchange, the US Commodity Futures Trading Commission, which oversees the futures market, is extending the review period to thoroughly study the operating mechanism of such contracts and seek opinions from the wider industry. The CFTC confirmed in a letter sent on September 21 that the product will not go live as scheduled next month. The CFTC stated that since the product involved “novel or complex” issues, regulators needed more time to evaluate CME's application and decided to extend the review period by 45 days until November 9.